Latest Glue News & Updates
See the latest news and media coverage for Glue. We track all announcements, press releases, and industry mentions in real time, all in one place.
Virtual collaboration platform
glue.work- Headquarters
- Helsinki, Finland
- Founded year
- 2017
- Company type
- Private company
- Number of employees
- 10–50
Last updated
Latest news about Glue
In short: Glue was acquired by Hyperspace and expanded its immersive virtual collaboration platform despite its former parent company facing bankruptcy.
Company announcements
-
Glue announces Horizon Workrooms ends February 16 2026
Teams relying on persistent rooms must save artifacts. Glue provides a step-by-step migration guide and checklist.
-
Glue supports PZU's transformation in team collaboration
Glue is collaborating with PZU to redefine meetings and adult education through innovative virtual and immersive technologies.
-
Glue highlights collaboration at Universität Münster in the Metaverse
Students and professors engaged in spontaneous, meaningful virtual connections showcasing spatial collaboration's potential beyond traditional video calls. Leadership emphasized immersive remote teamwork experiences.
-
Glue has been acquired by Hyperspace
Hyperspace completed its acquisition of Glue, promising continued service and enhanced virtual collaboration tools for users.
Media coverage
-
MONTE ROSA THERAPEUTICS ($GLUE) Releases Q1 2026 Earnings | Quiver Quantitative
MONTE ROSA THERAPEUTICS ($GLUE) posted quarterly earnings results for Q1 2026 on Thursday, May 7th. The company reported earnings of -$0.45 per share, missing estimates...
-
Erasca to Host Conference Call and Webcast to Discuss Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015
PM Eastern TimeSAN DIEGO, April 27, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and...
-
Kymera Therapeutics Announces Gilead Sciences' Option Exercise to License KT-200, Oral CDK2 Molecular Glue Degrader Development Candidate
KT-200 is a first-in-class, oral CDK2 molecular glue degrader development candidate Option exercise of KT-200 triggers a $45 million milestone payment to Kymera from Gilead...
-
FDA Grants Fast Track Status to ALK-Degrading Molecular Glue TRI-611
FDA fast track designation applies to ALK+ NSCLC progressing after ≥2 ALK TKIs, reflecting limited post-lorlatinib therapeutic options and enabling more frequent FDA interactions and...
Track Glue and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Glue competitors & trending companies
Browse news for competitors to Glue and other trending companies.
Teemyco
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove